Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocodone/Acetaminophen ER in Chronic Low Back Pain
NCT01364922Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Jun 2011
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of hydrocodone + acetaminophen in chronic low back pain (CLBP) (3 arms), sponsored by AbbVie Inc. Primary endpoint: Change From Double-blind Baseline in Chronic Lower Back Pain (CLBP) Intensity by Visual Analog Scale (VAS) at Day 29. Started Jun 2011; status: completed.
02
Drugs
hydrocodone + acetaminophen
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT01364922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01364922.